what happens if you don't eat enough on tirzepatide Not Eating Tirzepatide: Health Risks 20 Possible Tirzepatide Side Effects

In terms of the magnitude of fat mass reduction in controlled research settings: Semaglutide (GLP-1 alone): ~1015% body weight Tirzepatide (GLP-1 + GIP): ~1622% body weight Retatrutide (GLP-1 + GIP + Glucagon): ~2429% body weight (Phase 2 data) This stepwise increase with each additional receptor target is a remarkable demonstration of pharmacological synergy and has driven enormous interest in the triple-agonist research space

We expect that in the years to come, more highly effective medications will emerge, assisting those affected by obesity in their weight management journey

Tirzepatide is a dual GIP/GLP-1 receptor agonist that improves blood sugar control and promotes weight loss through multiple metabolic pathways

Heally itself does not prescribe medications or provide medical advice

Keep in close contact with your healthcare provider to manage side effects effectively

You do not add a separate pen needle to those devices